CN101289659B - Delta6 fatty acid desaturated enzyme of marine microalgae and applications thereof - Google Patents
Delta6 fatty acid desaturated enzyme of marine microalgae and applications thereof Download PDFInfo
- Publication number
- CN101289659B CN101289659B CN2008101152453A CN200810115245A CN101289659B CN 101289659 B CN101289659 B CN 101289659B CN 2008101152453 A CN2008101152453 A CN 2008101152453A CN 200810115245 A CN200810115245 A CN 200810115245A CN 101289659 B CN101289659 B CN 101289659B
- Authority
- CN
- China
- Prior art keywords
- ala
- leu
- val
- gly
- phe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000790 Enzymes Proteins 0.000 title claims description 9
- 102000004190 Enzymes Human genes 0.000 title claims description 8
- 150000004665 fatty acids Chemical class 0.000 title description 8
- 235000014113 dietary fatty acids Nutrition 0.000 title description 4
- 229930195729 fatty acid Natural products 0.000 title description 4
- 239000000194 fatty acid Substances 0.000 title description 4
- 108010037138 Linoleoyl-CoA Desaturase Proteins 0.000 claims abstract description 25
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 24
- 102100020754 Putative fatty acid desaturase 2-like protein FADS2B Human genes 0.000 claims abstract description 15
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 3
- 239000013604 expression vector Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 239000002253 acid Substances 0.000 abstract description 27
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract description 13
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract description 7
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract description 7
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract description 7
- 229960004488 linolenic acid Drugs 0.000 abstract description 7
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract description 6
- 235000020778 linoleic acid Nutrition 0.000 abstract description 5
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract description 5
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract description 4
- 229960002733 gamolenic acid Drugs 0.000 abstract description 4
- 125000000539 amino acid group Chemical group 0.000 abstract description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 74
- 239000013612 plasmid Substances 0.000 description 25
- 241000195493 Cryptophyta Species 0.000 description 19
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 17
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 17
- 241000196324 Embryophyta Species 0.000 description 16
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 15
- 150000002632 lipids Chemical class 0.000 description 14
- 239000000758 substrate Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000006555 catalytic reaction Methods 0.000 description 13
- 238000001228 spectrum Methods 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 108010022240 delta-8 fatty acid desaturase Proteins 0.000 description 12
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 102100034544 Acyl-CoA 6-desaturase Human genes 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 239000012452 mother liquor Substances 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 102220023258 rs387907548 Human genes 0.000 description 8
- 150000007513 acids Chemical class 0.000 description 7
- 230000003321 amplification Effects 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000009261 transgenic effect Effects 0.000 description 6
- 241000024188 Andala Species 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 229960004232 linoleic acid Drugs 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 102220369446 c.1274G>A Human genes 0.000 description 4
- 102220369447 c.1352G>A Human genes 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000032050 esterification Effects 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 102220023257 rs387907546 Human genes 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000013535 sea water Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 102000009114 Fatty acid desaturases Human genes 0.000 description 3
- 108010087894 Fatty acid desaturases Proteins 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 101150090932 ND6 gene Proteins 0.000 description 3
- 241000224474 Nannochloropsis Species 0.000 description 3
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 3
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102100034542 Acyl-CoA (8-3)-desaturase Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 108010073542 Delta-5 Fatty Acid Desaturase Proteins 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 101150009006 HIS3 gene Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 102220369445 c.668T>C Human genes 0.000 description 2
- -1 carboxyl carbon Chemical compound 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 235000014304 histidine Nutrition 0.000 description 2
- 150000002411 histidines Chemical class 0.000 description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 102220004457 rs11567847 Human genes 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000007826 Arachis sp Nutrition 0.000 description 1
- 244000298916 Arachis sp Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000220243 Brassica sp. Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101150094690 GAL1 gene Proteins 0.000 description 1
- 102100028501 Galanin peptides Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 241000490472 Helianthus sp. Species 0.000 description 1
- 101100121078 Homo sapiens GAL gene Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000208202 Linaceae Species 0.000 description 1
- 241000208204 Linum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 101100476480 Mus musculus S100a8 gene Proteins 0.000 description 1
- 229910004619 Na2MoO4 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000795633 Olea <sea slug> Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241001221668 Ostreococcus tauri Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000206744 Phaeodactylum tricornutum Species 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 206010039361 Sacroiliitis Diseases 0.000 description 1
- 240000006474 Theobroma bicolor Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 241000736893 Thunbergia Species 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 101150050575 URA3 gene Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229910052927 chalcanthite Inorganic materials 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000011208 chromatographic data Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000003653 coastal water Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000011655 cotton Nutrition 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000024732 dysthymic disease Diseases 0.000 description 1
- 150000002066 eicosanoids Chemical class 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention provides marine microalgae delta6-fatty acid desaturase, and coding genes and application thereof. The delta6-fatty acid desaturase is provided with amino acid sequences shown in a sequence table SEQ ID NO.2 or amino acid sequences which are formed by replacement, shortage or addition of one amino acid residue or a plurality of amino acid residues and have the same functions. The delta6-fatty acid desaturase can effectively catalyze Linoleic Acid (LA, 18:2delta9, 12) to generate gamma- Linolenic Acid (GLA, 18:3delta6, 9, 12) and catalyze alpha-Linolenic Acid (ALA, 18:3delta9, 12, 15) to generate Stearidnoic Acid (SDA, 18:4delta6, 9, 12, 15).
Description
Technical field
The invention belongs to biological technical field, be specifically related to Δ 6 fatty acid desaturases, its encoding gene and the application of a kind of marine microalgae-little plan ball algae.
Background technology
Lipid acid is the monocarboxylic acid with hydrocarbon chain, plays an important role in many biological procedureses.Lipid acid is less to be existed with the free form, but is advanced in the various main lipid composition, as phosphatide and triacylglycerol by fatization.Lipid acid mainly is divided into two classes: saturated fatty acid and unsaturated fatty acids, the latter is divided into monounsaturated fatty acids and polyunsaturated fatty acid again, contains one or more cis-double bondss (C=C) in its hydrocarbon chain respectively.
The generation of unsaturated link(age) needs fatty acid desaturase (fatty acid desaturase) catalysis.Fatty acid desaturase is present in nearly all plant, animal and the microorganism, the C-C singly-bound in the fatty acid chain can be converted into C=C pair and be good for.According to its position difference of introducing two keys, desaturase can be divided into Δ 5, Δ 6, Δ 9, Δ 12 etc., they introduce two keys at the 5th, 6,9,12 the carbon atom place that fatty acid chain is begun by carboxyl carbon respectively.The enzyme that adds two keys between the carboxyl carbon of fatty acid chain and the 9th carbon atom front end desaturase (front-enddesaturase) that is otherwise known as mainly comprises Δ 4, Δ 5, Δ 6, Δ 8 desaturases.People and other Mammals lack Δ 12 (ω 6) and Δ 15 (ω 3) desaturase, can not generate linolic acid (linoleic acid, LA; 18:2 Δ 9,12) and alpha-linolenic acid (α-linolenic acid, ALA; 18:3 Δ 9,12,15), must from food, replenish.Higher plant generally can only be synthesized to linoleic acid plus linolenic acid owing to lack the front end desaturase, can not continue the synthetic more polyunsaturated fatty acid of long-chain.And certain micro-organisms, particularly fungi, marine microalgae etc. then have synthesis of long-chain polyunsaturated fatty acids (long chainpolyunsaturated fatty acids, LCPUFAs) required all desaturases, can de novo synthesis LCPUFAs and content abundant (Sayanova and Napier, 2004).
LCPUFAs is meant the lipid acid (Abbadi et al., 2004) that contains 20 or 22 carbon atoms and 4-6 methene cis-double bonds at interval, comprises AA (arachidonic acid, 20:4 Δ 5,8,11,14), EPA (eicosapentaenoic acid, 20:5 Δ 5,8,11,14,17) and DHA (docosapentaenoic acid, 22:6 Δ 4,7,10,13,16,19) (be commonly called as " DHA (docosahexaenoic acid) ") etc.LCPUFAs can be divided into n6 series and n3 series according to last two bond length in the fatty acid chain from the distance of methyl end carbon atom.AA belongs to n6 LCPUFAs, and EPA and DHA belong to n3 LCPUFAs.Studies show that LCPUFAs has very important influence to human health.AA and EPA are the components of mammalian cell membrane, also are the precursors (Funk, 2001) that generates hormones such as prostaglandin(PG), leukotriene and thromboxane; EPA in various physiological responses such as blood coagulation, immunity and anti-inflammatory, play an important role (Simopoulos, 2002); DHA is to most important (the Uauy et al. of the formation of fetal nerve system, 2001), also affect activity (the Giusto et al. of retina Visual purple, 2000), and with prevention and treatment relevant (Horrocks and Yeo, 1999 of some disease such as sacroiliitis, arteriosclerosis, dysthymia disorders; Marszalek and Lodish, 2005).
AA, EPA and DHA are generated through a series of desaturations and extension by LA and ALA in vivo.At first LA and ALA generate GLA (18:3 Δ 6,9,12) and SDA (18:4 Δ 6,9,12,15) respectively under Δ 6 desaturase effects; Generate DGLA (20:3 Δ 8,11,14) and ETA (20:4 Δ 8,11,14,17) through Δ 6 extensions then; Generate AA (20:4 Δ 5,8,11,14) and EPA (20:5 Δ 5,8,11,14,17) by Δ 5 desaturase effects again; EPA can further generate DHA through two approach again.Though human body can be converted into AA, EPA and DHA with external source LA and ALA, combined coefficient is extremely low, can not satisfy the demand far away, takes in competent LCPUFAs (particularly EPA and DHA) and just seem particularly important in diet.
The source of current EPA and DHA mainly is a fish oil, yet along with the minimizing day by day with ocean harvestable fish class resource of increasing rapidly of the market requirement, this approach can not be satisfied the demand far away.In addition, reason such as environmental pollution causes the heavy metal content in the fish oil more and more higher.Therefore, seek more lasting, stable EPA and DHA source and become the task of top priority (Tononet al., 2002; Domergue et al., 2005a).Though now developed business-like algal oil and fungal oil, output that it is lower and higher extraction cost have limited the large-scale application of this class resource.The extraction process of considering vegetables oil is very ripe, many investigators have turned to sight the metabolic engineering of plant, explore and how to utilize existing front end desaturase and elongase gene particularly to make up the synthetic path of LCPUFAs in the oil crops, make it to become stable, cheap LCPUFAs source higher plant.Present this field Journal of Sex Research progress that made a breakthrough, the render transgenic plant produces EPA, DHA become a reality (Truksa etal., 2006) as " green cell factory ".
Δ 6 desaturases energy catalysis Linoleic Acid (18:2 Δ 9,12) generate γ-Linolenic Acid (18:3 Δ 6,9,12), and catalysis α-Linolenic Acid (18:3 Δ 9,12,15) generate Stearidnoic Acid (18:4 Δ 6,9,12,15), be the key enzyme of EPA and DHA generation thereafter.From animal, plant, fungi and marine microalgae, clone Δ 6 delta 8 desaturase genes now and carried out Function Identification.Leading a cow on the winged petiole mountain as Cohoon etc. detects Δ 6 acyl-ACP desaturases in (Thunberia alata) seed endosperm, means that the 1st two keys of lipid acid also may be in 6 generations of Δ (Cohoon et al., 1994).Clone from marine microalgae Ostreococcus tauri such as Domergue obtains an acyl group-CoA Δ 6 desaturases, and LA that this endonuclease capable catalysis is connected with CoA and ALA generate GLA and SDA (Domergue et al., 2005).But the Δ 6 desaturase quantity of commercial applications that can effectively be used in transgenic plant at present are few, and range of choice is narrow and small, and therefore continuing Δ 6 desaturases that clone and screening have higher Substratspezifitaet and catalytic activity is one of current research focuses.
Known little plan ball algae is rich in EPA, and high-content can reach more than 30% of total fatty acids, and Δ 6 desaturases may have high enzyme as EPA synthetic key enzyme and live.But do not see the relevant report of relevant little plan ball algae Δ 6 desaturases at present.
Summary of the invention
The object of the present invention is to provide a kind of little plan ball algae Δ 6 delta 8 desaturase genes, its proteins encoded and application.
Little plan ball algae Δ 6 delta 8 desaturase genes of the present invention have the nucleotide sequence shown in the SEQ ID NO.1, and its proteins encoded has the aminoacid sequence shown in the SEQ ID NO.2; The present invention also comprises the aminoacid sequence shown in the SEQ ID NO.2 through replacing, lack or add one or several amino acids formed derived protein with same function, and these proteinic genes of encoding.
The long 1425bp of Δ 6 delta 8 desaturase genes of the present invention, 474 amino acid of encoding.Carrying out the homology search in GenBank, do not find the sequence report identical with this gene, is a new gene.
Gene of the present invention can obtain in the following way: the cDNA that obtains with the total RNA reverse transcription of little plan ball algae is a template, utilize following primer to increase, the condition of Forward Primer:5 '-ATGGGACGCGGTGGCGAGCGG-3 ' Reverse Primer:5 '-TTACATGGCGGGGAAATCGGCC-3 ' amplification is: 94 ℃ of pre-sex change 3min, with 94 ℃ of 30s, 56 ℃ of 30s, 30 circulations of 72 ℃ of 1.5min reactions, 72 ℃ are extended 15min, 4 ℃ of preservations.
The present invention also comprises the expression vector that contains said gene, the host cell that contains described expression vector.
Δ 6 desaturases of the present invention have the peculiar N terminal cell of front end desaturase pigment b
5Structural domain and 3 Histidines bunch (176-180,215-219,413-417).
Δ 6 desaturases of the present invention are catalysis catalysis Linoleic Acid (18:2 Δ 9 effectively effectively, 12) generate γ-Linolenic Acid (18:3 Δ 6,9,12), and catalysis α-LinolenicAcid (18:3 Δ 9,12,15) generate Stearidnoic Acid (18:4 Δ 6,9,12,15).
Dna sequence dna of the present invention can be applied to comprise arbitrary expression system of animal, plant, microorganism, and the render transgenic cell generates LCPUFAs.For example, in the plant of oil crops flax (Linum sp.), rape (Brassica sp.), soybean (Glycine and Sola sp.), Sunflower Receptacle (Helianthus sp.), cotton (Gossypium sp.), corn (Zea mays), olive (Olea sp.), safflower (Carthamus sp.), cocoa (Theobroma cacca) and peanut (Arachis sp.) and seed, express this gene and Δ 5 desaturases, Δ 6 extends genes such as enzymes, can make above-mentioned plant generate EPA, DHA, have high business development and be worth.And EPA, DHA can be used as healthcare products or medicine is used for prevention and treatment of diseases, as diabetes, cancer, inflammatory reaction and cardiovascular disorder etc.
Description of drawings
Fig. 1 is Δ 6 fatty acid desaturase catalysis (18:2 Δs 9 of the present invention, 12) generate (18:3 Δ 6,9,12) chromatography of gases analytical results, wherein 1-A does not add the spectrum peak figure of substrate for changing sky pYES2 plasmid over to, and 1-B is the spectrum peak figure of the empty pYES2 plasmid of commentaries on classics of adding LA substrate, 1-C is the spectrum peak figure of the commentaries on classics pYND6 plasmid of adding LA substrate, and 1-D is standard control;
Fig. 2 is little plan ball algae Δ 6 fatty acid desaturase catalysis (18:3 Δs 9,12,15) generate (18:4 Δ 6,9,12,15) chromatography of gases analytical results, wherein 2-A does not add the spectrum peak figure of substrate for changing sky pYES2 plasmid over to, and 2-B is the spectrum peak figure of the empty pYES2 plasmid of commentaries on classics of adding ALA substrate, 2-C is the spectrum peak figure of the commentaries on classics pYND6 plasmid of adding ALA substrate, and 2-D is standard control.
Embodiment
Following embodiment be used for to of the present inventionly advance-go on foot explanation, but be not used for limiting the scope of the invention.
The acquisition of embodiment 1 Δ 6 saturated enzyme genes
Concrete steps comprise:
1, the cultivation of little plan ball algae
1) little plan ball algae Nannochloropsis.oculata (Droop) Hibberd for purebred cultivation, is numbered CS-179 available from the little algae germplasm of Australian CSIRO storehouse (CSIRO Collection of Living Microalgae)
2) cultivating with seawater is coastal waters, Qingdao nature seawater, and seawater filters through absorbent cotton, and 100 ℃ are boiled 3min.250ml Erlenmeyer flask and transfer pipet etc. all with preceding autoclaving (121 ℃, 15min).
3) preparation f/2 mother liquor and sterilization.
4) ratio in 1: 1000 (v/v) adds the f/2 mother liquor in the sterilization seawater, and the ratio access algae kind in 1: 10 (v/v) places illumination box not inflate cultivation, shakes bottle every day for several times.Concrete culture condition sees Table 1.
The culture condition of the little plan ball of table 1 algae
The preparation of f/2 mother liquor
1. fundamental element:
NaNO3 78.4g+1L DDW (distilled water);
NaSiO3·9H2O 10g+1L?DDW
NaH2PO4 4.4g+1L?DDW
Mentioned reagent autoclaving (121 ℃, 15 minutes) adds 1ml in every 1000ml nutrient solution.
2. micro-:
ZnSO4·4H2O 2.3g
MnCl2·4H2O 17.8g
CuSO4·5H2O 1g
Na2MoO4·2H2O 0.73g
CoCl2·6H2O 1.2g
Na2EDTA 5g
Mentioned reagent is dissolved among the 100mlDDW, gets the 1ml mixed solution and adds among the 1L DDW, and other adds 4.3 gram Na2EDTA, and the micro-mother liquor for preparing stores behind remaining mixed solution autoclaving.Add 1ml trace element mother liquor during use in every 1000ml nutrient solution.
3.Fe element
FeC6H5O7·5H2O 39g+100ml?DDW
Get 10ml and add among the 1L DDW, store with the rest solution autoclaving as mother liquor.Add the 1ml mother liquor during use in every 1000ml nutrient solution.Fe also can fit over micro-mother liquor, also is to add 10ml.
4. VITAMIN
VB12 0.5mg
VB1 100mg
VH 0.5mg
The bottled 1L DDW of brown reagent autoclaving adds said vitamin, 4 ℃ of storages after reducing to room temperature.Add 1ml VITAMIN mother liquor during use in every 1000ml nutrient solution.
4) observe the growing state of algae every day, algae liquid yellow-green colour during little plan ball algae normal growth, but the frond long period be suspended in the substratum, microscopy is carried out in the cultivation of regularly going down to posterity when going down to posterity, observe to have or not frond adhesion or harmful organisms to pollute.
2, mRNA extracts
MRNA extraction and application TR1zol reagent (Invitrogen, Cat.No.15596-026) cracking, be used in combination RANprep Plant Kit (TIANGEN, Cat.No.DP402-02).Carry out the RNA purifying, detailed process is seen the reagent working instructions.
3, library construction
1) cDNA preparation:
Utilize SMART
TMPCR cDNA Synthesis Kit (Clontech, Cat.No.634902), preparation cDNA, detailed process is seen the reagent working instructions.
2) the cDNA segmentation is reclaimed, is connected:
1. get the homogenization cDNA product electrophoresis of 200 μ l secondaries amplifications, reclaim 0.5-1.0kb respectively, 1.0-1.5kb, 1.5-2.0kb and>the purpose fragment of 2.0kb;
3. carrier is connected (T4DNA ligase) with the insertion fragment with about 1: 3 ratio.
3) heat shock transforms
1. get 4 μ L and connect product, add in the 100 μ L competent cells mixing, precooling 20min on ice;
2. 42 ℃ of heat shock 45s;
3. behind the cooled on ice 2min, add 0.9ml SOC liquid nutrient medium;
4. 70rpm, 37 ℃, recovery 60min;
5. get 5 μ L bacterium liquid and be coated with LB (Ampr) flat board, X-Gal, IPTG screening was cultivated 16 hours for 37 ℃.
4) cDNA library order-checking
Picking mono-clonal at random from the flat board, LB cultivates, and send associating Gene science (group) company limited (www.chinagenenet.com) to check order after PCR detects.
5) sequencing result is carried out the Blastx comparison in GenBank, find a sequence and hailian seaweed, Δ 6 delta 8 desaturase genes of little algae such as Phaeodactylum tricornutum have very high similarity, tentatively confirm as little plan ball algae Δ 6 delta 8 desaturase genes 3 ' sequence.
4,5 ' RACE obtains 5 ' sequence of Δ 6 delta 8 desaturase genes
Use 5 ' RACE test kit to be: 5 ' RACE System for Rapid Amplification ofcDNA Ends, Version 2.0 (Invitrogen, Cat.No.15590-101).In the experiment each reagent be if no special instructions test kit from carries product, detailed process sees the test kit working instructions for details.According to outer primer in following design 5 ' the RACE nest-type PRC of 3 ' sequences Design
ND (outward): 5 ,-GTTCATGGCCACGAAGTAGAGACC-3,
ND (interior): 5 ,-CAGTCGCGTACGAATGCCAGCAGA-3,
The fragment that obtains cuts obvious band behind the electrophoresis, T-A connects, and transforms, and the bacterial strain that is accredited as positive colony send company's order-checking.Order-checking identifies that the fragment that a length is about 900bp is Δ 6 fatty acid desaturase gene 5 ' sequences.
5, the acquisition of the full gene of Δ 6 fatty acid desaturases
1) according to 3 ' and 5 ' terminal sequence information, search the reading frame in the GenBank comparison, design following primer (two ends band Kpn I and Sac I restriction enzyme site):
ND-Kpn?I-F:
5′-CGGGTACCACCATGGCACGGGATGGCGAGCCGGTCG-3’
ND-Sac?I-R:
5′-GCGGAGCTCTTCGCTTCCCTCCGTCCGTTTACACAG-3’
The cDNA product that obtains during 2) with the structure library is a masterplate, and amplification obtains the full gene of Δ 6 fatty acid desaturases, and the PCR reaction system is as follows:
Sterilized,distilled?water 36.5μl
10×PCR?buffer 5.0μl
10mM?dNTP?mix 1.0μl
ND-Kpn?I-F(10μM) 1.0μl
ND-Sac?I-R(10μM) 1.0μl
cDNA 5.0μl
Cumulative volume _ 49.5 μ l
Add high-fidelity DNA polymerase (5U/ μ l) mixing immediately, following condition is carried out pcr amplification: 94 ℃, and 2m → (94 ℃, 30s → 55 ℃, 30s → 72 ℃, 1m) * and 35cycles → 72 ℃, 7min
Amplification has obtained the coding region of this gene, and connects into pGEM-T plasmid commentaries on classics JM109 preservation, and sequence verification obtains Δ 6 delta 8 desaturase genes, and its nucleotide sequence is shown in SEQ ID NO.1.
6, according to above-mentioned sequencing result, Δ 6 fatty acid desaturase mrna lengths from little plan ball algae are 1425bp, 474 amino-acid residues of encoding, its amino acid sequence coded is shown in sequence table SEQ ID NO.2, this sequence has the feature structure territory of front end desaturase, comprises N terminal cell pigment b5 structural domain and 3 Histidines bunch (176-180,215-219,413-417).
The structure of embodiment 2 expression vector pYND6 and the conversion of yeast saccharomyces cerevisiae
1, yeast saccharomyces cerevisiae expression vector pYES2 and yeast strain INVSc1 brief introduction
The experiment expression vector is selected pYES2 plasmid (Invitrogen for use, Cat.No.V825-20), long 5857bp, have the GAL1 promotor, this promotor is an induction type, have glucose (glucose) to transcribe when existing in substratum and be suppressed, removing glucose adding semi-lactosi then can inducible transcription.In addition, cell can also be grown in the substratum of raffinose (raffinose) as carbon source, and raffinose is neither induced and also do not suppressed to transcribe, and inducedvelocity is that the carbon source cultured cells is fast than beginning with glucose.
The genotype of yeast INVSc1 is MATa his3 Δ 1 leu2 trp1-289 ura3-52/MAT α his3 Δ 1 leu2 trp1-289 ura3-52, and phenotype is His
-, Leu
-, Trp
-, Ura
-Plasmid pYES2 has the URA3 gene, the minimal medium screening yeast transformant of available shortage uridylic.Other details are referring to the pYES2 specification sheets of Invitrogen.
2, the screening of the structure of expression vector pYND6 and positive colony
1) the positive bacterium colony of the JM109 that contains pGEM-Δ 6 delta 8 desaturase genes that obtains among the amplification cultivation embodiment 1.
2) extract the pGEM plasmid that has Δ 6 delta 8 desaturase genes according to ordinary method, utilize corresponding D NA restriction endonuclease (Kpn I/Sac I), from the pGEM plasmid that inserts goal gene, cut gene, utilize corresponding restriction endonuclease combination simultaneously, the pYES2 plasmid is cut into the line style double-stranded DNA.
The restriction endonuclease reaction reagent is pressed following proportioning:
nuclease-free?water 15μl
10×Buffer 2μl
DNA/ plasmid 1 μ l
Restriction endonuclease 2 μ l
Cumulative volume 20 μ l
37 ℃ of reactions are spent the night, and product is cut glue and reclaimed purifying
3) carrier connects
Delta 8 desaturase genes after restriction endonuclease handled with cut the pYES2 plasmid and mix with 2: 1 volume ratios, press following proportioning mixed reaction solution:
DNA﹠amp; Plasmid 10 μ l
10×Buffer 2μl
nuclease-free?water 6μl
T4?DNA?Ligase 2μl
Cumulative volume 20 μ l
More than 22 ℃ of reaction 1h, the 5 μ l reaction product heat shock methods of getting change JM109 over to, and coated plate is chosen mono-clonal and cultivated, bacterium liquid PCR check back sequence verification.
Thus, make up and finish expression vector pYND6, will contain the e. coli jm109 amplification cultivation of expression vector, and extract plasmid, yeast conversion is prepared in-20 ℃ of preservations.
3, the preparation of yeast saccharomyces cerevisiae competent cell and conversion.
The preparation of the yeast saccharomyces cerevisiae competent cell of this experiment and trans-utilization EasyCompTM conversion reagent box (Invitrogen, Catalog no.K5050-01), specific operation process is seen the test kit working instructions.
Yeast after the conversion evenly is applied to SC-U-flat board (placing 1h for dull and stereotyped prior 30 ℃), and 30 ℃ of thermostat containers are cultivated 3d; Picking yeast list bacterium colony is cultivated, and extracts zymic DNA, is PCR with specially primer ND-Kpn I-F and ND-Sac I-R and detects, and the contrast of commentaries on classics empty plasmid is set.It is the positive colony that changes the ND6 gene over to that PCR can access this yeast of the segmental expression of purpose, can be used for expressing experiment.
Abduction delivering and the fatty acid analysis of embodiment 3 yeast strains
1. abduction delivering
1) will contain the positive colony of recombinant plasmid and empty plasmid contrast bacterium and rule on SC-U (2%glucose) flat board once more, 30 ℃ are cultured to and grow bacterium colony;
2) choose mono-clonal and insert 3ml SC-U (2%glucose) liquid nutrient medium, 30 ℃ are shaken bacterium and spend the night;
3) it is centrifugal to get an amount of bacterium liquid, adds 3.6mlSC-U (2%glucose), to initial OD
600About 0.2, add 400 μ l20%NP-40 (final concentration is 1%), add lipid acid substrate (LA, 18:2 Δ 9,12 and ALA, 18:3 Δ 9,12,15) simultaneously and, induce 72h for 20 ℃ to final concentration 25uM.
2. lipid acid extracts and analyzes
2.1 lipid acid extracts and esterification
1) the bacterium liquid 5000rpm after will inducing, the centrifugal collection of 3min;
2) liquid nitrogen grinding changes the dry powder after grinding in the EP pipe over to, adds the saturated methyl alcohol of 300 μ l KOH, 70-80 ℃ of saponification 15-20min after the vortex mixed;
3) add the HCl-methyl alcohol of excessive 1N concentration, vortex mixing, 70-80 ℃ of esterification 15min after the cooling;
4) add an amount of normal hexane, and drench a small amount of distilled water, the layering extraction;
5) behind the centrifugal 5min of 12000rpm, carefully get the upper strata organic layer, promptly can be used for gas phase analysis.
2.2 the gas-chromatography of lipid acid (GC) is analyzed
1) instrument: the 5890 SERIES II of Hewlett-Packard;
Carrier gas: N
2Linear speed: 20cm/s; Splitting ratio: 10: 1
Flow: 2.2ml/min; Temperature of vaporization chamber: 260 ℃;
Temperature programming: 150 ℃ of (2min) → 15 ℃/min rises to 200 ℃ of (0min) → 2 ℃/min and rises to 250 ℃ (15min);
Detector: flame ionization ditector (FID);
2) be standard substance behind the various methyl esterification of fatty acid with the production of Cayman company;
3) the lipid acid sample with standard substance and above-mentioned esterification carries out the GC analysis, and applied sample amount is 1-2 μ l.
4) analysis software: SPSIII type chromatographic data treatment system.
3. experimental result
Gas chromatographic analysis shows, change lipid acid substrate Linoleic Acid (the 18:2 Δ 9 that external source can be added behind the yeast abduction delivering of pYND6 over to, 12) catalysis generates γ-Linolenic Acid (18:3 Δ 6,9,12), and catalysis α-Linolenic Acid (18:3 Δ 9,12,15) generate Stearidnoic Acid (18:4 Δ 6,9,12,15).The albumen that institute's transgenes encoding is described has the function of Δ 6 fatty acid desaturases really, confirms as Δ 6 fatty acid desaturases of little plan ball algae.
Gas chromatographic analysis such as Fig. 1, shown in 2, Fig. 1 is result behind the adding LA, wherein 1-A does not add the spectrum peak figure of substrate for changing sky pYES2 plasmid over to, and 1-B is the spectrum peak figure of the empty pYES2 plasmid of commentaries on classics of adding LA substrate, 1-C is the spectrum peak figure of the commentaries on classics pYND6 plasmid of adding LA substrate, and 1-D is standard control.The interference at peak though have powerful connections, but can see significantly that the ND6 gene can obtain activity expression in yeast, catalysis LA generates DLA, and blank does not have this function.
Fig. 2 is for adding ALA result.Wherein 2-A does not add the spectrum peak figure of substrate for changing sky pYES2 plasmid over to, and 2-B is the spectrum peak figure of the empty pYES2 plasmid of commentaries on classics of adding ALA substrate, and 2-C is the spectrum peak figure of the commentaries on classics pYND6 plasmid of adding ALA substrate, and 2-D is standard control.The interference at peak though have powerful connections, but can see significantly that the ND6 gene can obtain activity expression in yeast, catalysis ALA generates SDA (the spectrum peak of SDA is than the obvious height of background peaks), and blank does not have this function.
N6 transformation efficiency ratio:
18:2 Δ 9,12 and 18:3 Δ 6,9,12 shared per-cent in analysis chart are respectively 6.63 and 3.92, and its transformation ratio is: 6.63+3.92
18:3Δ6,9,12/(18:2Δ9,12+18:3Δ6,9,12)
=3.92/(6.63+3.92)=37%
N3 transformation efficiency ratio:
(18:3 Δ 9,12,15) and (18:4 Δ 6,9,12,15) shared per-cent is respectively 7.74 and 5.86 in analysis chart, and its transformation ratio is:
(18:4Δ6,9,12,15)/(18:3Δ9,12,15+18:4Δ6,9,12,15)
=5.86/(7.74+5.86)=43%
Reference:
Domergue?F,?Lerchl?J,Zahringer?U,Heinz?E(2002).Cloning?and?functional?characterization?ofPhaeodactylum?tricornutum?front-end?desaturases?involved?in?dicosapenaenoic?acidbiosynhesis.Eur?J?Biochem?269,4105-4113.
Abbadi?A,Domergue?F,Bauer?J,Napier?JA,Welti?R,Zahringer?U,Cirpus?P,Heinz?E(2004).Biosynthesis?of?very?long-chain?polyunsaturated?fatty?acids?in?transgenic?oilseeds:constraints?ontheir?accumulation.Plant?Cell?16,2734-2748.
Cahoon?EB,Cranmer?AM,Shanklin?J?and?Ohlrogge?JB.1994.Hexadecenoic?acid?is?synthesized?bythe?activity?of?a?soluble?Δ6-palmitoyl-acyl?carrier?protein?desaturase?in?Thunbergia?alataendosperm.J.Biol.Chem.269:27519-26
Domergue?F,Abbadi?A,Heinz?E(2005a).Relief?for?fish?stocks:oceanic?fatty?acids?in?transgenicoilseeds.Trends?Plant?Sci?10,112-116.
Funk?CD(2001).Prostaglandins?and?leukotrienes:advances?in?eicosanoid?biology.Science?294,1871-1875.
Giusto?NM,Pasquare?SJ,Salvador?PI,Roque?ME,Ilincheta?de?Boschero?MG?2000.Lipidmetabolism?in?vertebrate?retinal?rod?outer?segments.Prog.Lipid?Res?39,315-319.
Horrocks?LA,Yeo?YK(1999).Healthbenefits?of?docosahexaenoic?acid(DHA).Pharmacol?Res?40,211-215.
Marszalek?JR,Lodish?HF(2005).Docosahexaenoic?acid,fatty?acid-interacting?proteins,andneuronal?function:breastmilk?and?fish?are?good?for?you.Annu?Rev?Cell?Dev?Biol?21,633-657.
Qi?B,Fraser?T,Mugford?S,Dobson?G,Sayanova?O,Butler?J,Napier?JA,Lazarus?CM(2004).Production?of?very?long?chain?polyunsaturated?omega-3?and?omega-6?fatty?acids?in?plants.NatBiotechnol?22,739-745.
Sayanova?O,Napier?JA(2004).Eicosapentaenoic?acid:biosynthetic?routes?and?the?potential?forsynthesis?in?transgenic?plants.Phytochemistry?65,147-158.
Simopoulos?AP(2002).Omega-3?fatty?acids?in?inflammation?and?autoimmune?diseases.J?Am?CollNutr?21,495-505.
Tonon?T,Larson?TR,Graham?IA(2002).Long?chain?polyunsaturated?fatty?acid?production?andpartitioning?to?triacylglycerols?in?four?microalgae.Phytochemistry?61,15-24.
Truksa?M,Wu?G,Vrinten?V,Qiu?X(2006).Metabolic?engineering?of?plants?to?produce?verylong-chain?polyunsaturated?fatty?acids.Transgenic?Res?15,131-137.
Uauy?R,Hoffman?DR,Peirano?P,Birch?DG,Birch?EE(2001).Essential?fatty?acids?in?visual?andbrain?development.Lipids?36,885-895.
Wu?G,Truksa?M,Datla?N,Vrinten?P,Bauer?J,Zank?T,Cirpus?P,Heinz?E,Qiu?X(2005).Stepwise?engineering?to?produce?high?yields?of?very?long-chain?polyunsaturated?fatty?acids?inplants.Nat?Biotechnol?23,1013-1017.
Sequence table
<110〉Chinese Marine University
<120〉a kind of marine microalgae delta6 fatty acid desaturase and application thereof
<130>
<160>8
<170>PatentIn?version?3.3
<210>1
<211>1425
<212>DNA
<213>Nannochloropsis.oculata
<220>
<221>CDS
<222>(1)..(1425)
<400>1
atg?gca?cgg?gat?ggc?gag?ccg?gtc?gag?acg?acg?gag?tct?ttg?agc?ttc 48
Met?Ala?Arg?Asp?Gly?Glu?Pro?Val?Glu?Thr?Thr?Glu?Ser?Leu?Ser?Phe
1 5 10 15
acg?gcc?gac?aag?gcg?ggg?acc?atc?aag?cag?cgt?ggg?cgg?aag?atc?aca 96
Thr?Ala?Asp?Lys?Ala?Gly?Thr?Ile?Lys?Gln?Arg?Gly?Arg?Lys?Ile?Thr
20 25 30
tgg?gat?gag?gtg?cgt?cag?cac?aag?acg?cct?cag?gac?gct?tgg?ctc?gtg 144
Trp?Asp?Glu?Val?Arg?Gln?His?Lys?Thr?Pro?Gln?Asp?Ala?Trp?Leu?Val
35 40 45
tat?agg?aat?aag?gtc?tac?gac?gtg?tcg?agc?tgg?caa?gat?cac?ccc?ggg 192
Tyr?Arg?Asn?Lys?Val?Tyr?Asp?Val?Ser?Ser?Trp?Gln?Asp?His?Pro?Gly
50 55 60
ggg?aac?gtc?atc?ttc?act?cac?gcc?ggc?ggg?gac?tgc?acg?gat?att?ttc 240
Gly?Asn?Val?Ile?Phe?Thr?His?Ala?Gly?Gly?Asp?Cys?Thr?Asp?Ile?Phe
65 70 75 80
gcg?gcg?ttc?cac?cct?ctt?ggc?gcc?acc?tct?tat?ctt?gat?cca?ttt?tac 288
Ala?Ala?Phe?His?Pro?Leu?Gly?Ala?Thr?Ser?Tyr?Leu?Asp?Pro?Phe?Tyr
85 90 95
att?ggc?gag?ctg?gag?ccg?cgc?tcg?gac?aag?aag?ccc?gca?gcg?cag?gcg 336
Ile?Gly?Glu?Leu?Glu?Pro?Arg?Ser?Asp?Lys?Lys?Pro?Ala?Ala?Gln?Ala
100 105 110
aac?ttt?gag?cgc?gcc?tac?agg?gat?ctc?agg?ggg?aag?ctt?atc?gcg?ggt 384
Asn?Phe?Glu?Arg?Ala?Tyr?Arg?Asp?Leu?Arg?Gly?Lys?Leu?Ile?Ala?Gly
115 120 125
ggg?ttt?ttc?aag?gcg?aat?cct?ttg?tac?tat?gtc?tgg?aag?gta?gta?tcg 432
Gly?Phe?Phe?Lys?Ala?Asn?Pro?Leu?Tyr?Tyr?Val?Trp?Lys?Val?Val?Ser
130 135 140
tca?gtt?gcc?ctt?gct?gta?ggt?gcg?tgg?gtg?ctg?gtg?gct?tgg?tcg?cag 480
Ser?Val?Ala?Leu?Ala?Val?Gly?Ala?Trp?Val?Leu?Val?Ala?Trp?Ser?Gln
145 150 155 160
aac?ctg?ggc?gtg?cag?atg?ctg?tct?gcg?ttt?ttg?gtg?gct?ctg?ttc?tgg 528
Asn?Leu?Gly?Val?Gln?Met?Leu?Ser?Ala?Phe?Leu?Val?Ala?Leu?Phe?Trp
165 170 175
cag?caa?tgt?ggc?tgg?ttg?gcc?cat?gac?ttc?ctg?cac?cac?cag?gta?ttt 576
Gln?Gln?Cys?Gly?Trp?Leu?Ala?His?Asp?Phe?Leu?His?His?Gln?Val?Phe
180 185 190
aag?aac?cgt?gcg?ttg?ggt?gac?ctg?gcc?ggc?atc?gtt?atc?ggc?aat?gtc 624
Lys?Asn?Arg?Ala?Leu?Gly?Asp?Leu?Ala?Gly?Ile?Val?Ile?Gly?Asn?Val
195 200 205
ttc?cag?ggt?ttc?tcc?gtg?gca?tgg?tgg?aag?aac?aag?cat?aac?act?cac 672
Phe?Gln?Gly?Phe?Ser?Val?Ala?Trp?Trp?Lys?Asn?Lys?His?Asn?Thr?His
210 215 220
cac?gcg?gtg?ccc?aac?ctc?gtc?gag?tcc?tct?ccg?gac?gcg?caa?gac?gca 720
His?Ala?Val?Pro?Asn?Leu?Val?Glu?Ser?Ser?Pro?Asp?Ala?Gln?Asp?Ala
225 230 235 240
gac?cct?gac?att?gac?acc?atg?ccc?ata?ctg?gcc?tgg?tcg?ctc?aag?atg 768
Asp?Pro?Asp?Ile?Asp?Thr?Met?Pro?Ile?Leu?Ala?Trp?Ser?Leu?Lys?Met
245 250 255
gcc?gac?agg?gcg?cag?caa?tac?tca?tgg?gga?ccc?ttc?ttt?gtc?agg?cat 816
Ala?Asp?Arg?Ala?Gln?Gln?Tyr?Ser?Trp?Gly?Pro?Phe?Phe?Val?Arg?His
260 265 270
cag?tcg?ctg?cta?tac?ttc?ccc?atc?ctg?ctc?gtg?gcg?cgg?att?tca?tgg 864
Gln?Ser?Leu?Leu?Tyr?Phe?Pro?Ile?Leu?Leu?Val?Ala?Arg?Ile?Ser?Trp
275 280 285
ttg?atg?cag?tcg?ttc?ttg?ttt?gtc?ttt?gac?tcc?gtc?cct?gga?gcg?agt 912
Leu?Met?Gln?Ser?Phe?Leu?Phe?Val?Phe?Asp?Ser?Val?Pro?Gly?Ala?Ser
290 295 300
ctg?tgg?gca?acc?aag?ggc?gcg?acg?gct?gag?aga?cag?gcg?atc?aag?aat 960
Leu?Trp?Ala?Thr?Lys?Gly?Ala?Thr?Ala?Glu?Arg?Gln?Ala?Ile?Lys?Asn
305 310 315 320
gtc?ggg?ttg?gag?aag?gtg?ggg?ctg?gtt?gcg?cac?tac?ctg?tgg?tac?ggt 1008
Val?Gly?Leu?Glu?Lys?Val?Gly?Leu?Val?Ala?His?Tyr?Leu?Trp?Tyr?Gly
325 330 335
gcg?ctg?atg?ctg?tgc?cac?atg?tcc?ctg?gcc?cgc?gcc?ctg?ctg?tac?ttc 1056
Ala?Leu?Met?Leu?Cys?His?Met?Ser?Leu?Ala?Arg?Ala?Leu?Leu?Tyr?Phe
340 345 350
ctg?ccg?agc?cag?atg?atg?tgc?ggg?ttc?ttg?ctc?gcg?ctt?gtt?ttc?ggg 1104
Leu?Pro?Ser?Gln?Met?Met?Cys?Gly?Phe?Leu?Leu?Ala?Leu?Val?Phe?Gly
355 360 365
ctt?ggg?cac?aac?ggc?atg?gat?gtt?tac?gac?gcg?gac?gcc?cgg?ccc?gac 1152
Leu?Gly?His?Asn?Gly?Met?Asp?Val?Tyr?Asp?Ala?Asp?Ala?Arg?Pro?Asp
370 375 380
ttc?tgg?aag?ctg?cag?gtg?acg?acg?acg?agg?aac?gtg?acg?ggc?tcg?tgg 1200
Phe?Trp?Lys?Leu?Gln?Val?Thr?Thr?Thr?Arg?Asn?Val?Thr?Gly?Ser?Trp
385 390 395 400
ttg?gtg?cag?tgg?ttc?tgt?ggc?ggc?ctc?ggc?tac?cag?gtg?gac?cac?cac 1248
Leu?Val?Gln?Trp?Phe?Cys?Gly?Gly?Leu?Gly?Tyr?Gln?Val?Asp?His?His
405 410 415
ctg?ttc?ccc?atg?atc?ccg?cgg?cac?cgc?cta?ggg?aag?ctc?cac?ggg?ctc 1296
Leu?Phe?Pro?Met?Ile?Pro?Arg?His?Arg?Leu?Gly?Lys?Leu?His?Gly?Leu
420 425 430
gtg?gag?ggt?ttc?tgc?aag?gat?cac?ggg?gtg?aag?tac?cac?gag?acg?aat 1344
Val?Glu?Gly?Phe?Cys?Lys?Asp?His?Gly?Val?Lys?Tyr?His?Glu?Thr?Asn
435 440 445
atg?tgg?gag?ggg?acc?aaa?gag?gtg?ttg?gct?cac?ttg?agc?agt?gtg?acg 1392
Met?Trp?Glu?Gly?Thr?Lys?Glu?Val?Leu?Ala?His?Leu?Ser?Ser?Val?Thr
450 455 460
aaa?gag?ttc?gtg?gcc?gat?ttc?gcc?gct?gtg?taa 1425
Lys?Glu?Phe?Val?Ala?Asp?Phe?Ala?Ala?Val
465 470
<210>2
<211>474
<212>PRT
<213>Nannochloropsis.oculata
<400>2
Met?Ala?Arg?Asp?Gly?Glu?Pro?Val?Glu?Thr?Thr?Glu?Ser?Leu?Ser?Phe
1 5 10 15
Thr?Ala?Asp?Lys?Ala?Gly?Thr?Ile?Lys?Gln?Arg?Gly?Arg?Lys?Ile?Thr
20 25 30
Trp?Asp?Glu?Val?Arg?Gln?His?Lys?Thr?Pro?Gln?Asp?Ala?Trp?Leu?Val
35 40 45
Tyr?Arg?Asn?Lys?Val?Tyr?Asp?Val?Ser?Ser?Trp?Gln?Asp?His?Pro?Gly
50 55 60
Gly?Asn?Val?Ile?Phe?Thr?His?Ala?Gly?Gly?Asp?Cys?Thr?Asp?Ile?Phe
65 70 75 80
Ala?Ala?Phe?His?Pro?Leu?Gly?Ala?Thr?Ser?Tyr?Leu?Asp?Pro?Phe?Tyr
85 90 95
Ile?Gly?Glu?Leu?Glu?Pro?Arg?Ser?Asp?Lys?Lys?Pro?Ala?Ala?Gln?Ala
100 105 110
Asn?Phe?Glu?Arg?Ala?Tyr?Arg?Asp?Leu?Arg?Gly?Lys?Leu?Ile?Ala?Gly
115 120 125
Gly?Phe?Phe?Lys?Ala?Asn?Pro?Leu?Tyr?Tyr?Val?Trp?Lys?Val?Val?Ser
130 135 140
Ser?Val?Ala?Leu?Ala?Val?Gly?Ala?Trp?Val?Leu?Val?Ala?Trp?Ser?Gln
145 150 155 160
Asn?Leu?Gly?Val?Gln?Met?Leu?Ser?Ala?Phe?Leu?Val?Ala?Leu?Phe?Trp
165 170 175
Gln?Gln?Cys?Gly?Trp?Leu?Ala?His?Asp?Phe?Leu?His?His?Gln?Val?Phe
180 185 190
Lys?Asn?Arg?Ala?Leu?Gly?Asp?Leu?Ala?Gly?Ile?Val?Ile?Gly?Asn?Val
195 200 205
Phe?Gln?Gly?Phe?Ser?Val?Ala?Trp?Trp?Lys?Asn?Lys?His?Asn?Thr?His
210 215 220
His?Ala?Val?Pro?Asn?Leu?Val?Glu?Ser?Ser?Pro?Asp?Ala?Gln?Asp?Ala
225 230 235 240
Asp?Pro?Asp?Ile?Asp?Thr?Met?Pro?Ile?Leu?Ala?Trp?Ser?Leu?Lys?Met
245 250 255
Ala?Asp?Arg?Ala?Gln?Gln?Tyr?Ser?Trp?Gly?Pro?Phe?Phe?Val?Arg?His
260 265 270
Gln?Ser?Leu?Leu?Tyr?Phe?Pro?Ile?Leu?Leu?Val?Ala?Arg?Ile?Ser?Trp
275 280 285
Leu?Met?Gln?Ser?Phe?Leu?Phe?Val?Phe?Asp?Ser?Val?Pro?Gly?Ala?Ser
290 295 300
Leu?Trp?Ala?Thr?Lys?Gly?Ala?Thr?Ala?Glu?Arg?Gln?Ala?Ile?Lys?Asn
305 310 315 320
Val?Gly?Leu?Glu?Lys?Val?Gly?Leu?Val?Ala?His?Tyr?Leu?Trp?Tyr?Gly
325 330 335
Ala?Leu?Met?Leu?Cys?His?Met?Ser?Leu?Ala?Arg?Ala?Leu?Leu?Tyr?Phe
340 345 350
Leu?Pro?Ser?Gln?Met?Met?Cys?Gly?Phe?Leu?Leu?Ala?Leu?Val?Phe?Gly
355 360 365
Leu?Gly?His?Asn?Gly?Met?Asp?Val?Tyr?Asp?Ala?Asp?Ala?Arg?Pro?Asp
370 375 380
Phe?Trp?Lys?Leu?Gln?Val?Thr?Thr?Thr?Arg?Asn?Val?Thr?Gly?Ser?Trp
385 390 395 400
Leu?Val?Gln?Trp?Phe?Cys?Gly?Gly?Leu?Gly?Tyr?Gln?Val?Asp?His?His
405 410 415
Leu?Phe?Pro?Met?Ile?Pro?Arg?His?Arg?Leu?Gly?Lys?Leu?His?Gly?Leu
420 425 430
Val?Glu?Gly?Phe?Cys?Lys?Asp?His?Gly?Val?Lys?Tyr?His?Glu?Thr?Asn
435 440 445
Met?Trp?Glu?Gly?Thr?Lys?Glu?Val?Leu?Ala?His?Leu?Ser?Ser?Val?Thr
450 455 460
Lys?Glu?Phe?Val?Ala?Asp?Phe?Ala?Ala?Val
465 470
<210>3
<211>21
<212>DNA
<213〉artificial sequence
<400>3
atgggacgcg?gtggcgagcg?g 21
<210>4
<211>22
<212>DNA
<213〉artificial sequence
<400>4
ttacatggcg?gggaaatcgg?cc 22
<210>5
<211>24
<212>DNA
<213〉artificial sequence
<400>5
gttcatggcc?acgaagtaga?gacc 24
<210>6
<211>24
<212>DNA
<213〉artificial sequence
<400>6
cagtcgcgta?cgaatgccag?caga 24
<210>7
<211>36
<212>DNA
<213〉artificial sequence
<400>7
cgggtaccac?catggcacgg?gatggcgagc?cggtcg 36
<210>8
<211>36
<212>DNA
<213〉artificial sequence
<400>8
gcggagctct?tcgcttccct?ccgtccgttt?acacag 36
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101152453A CN101289659B (en) | 2008-06-19 | 2008-06-19 | Delta6 fatty acid desaturated enzyme of marine microalgae and applications thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101152453A CN101289659B (en) | 2008-06-19 | 2008-06-19 | Delta6 fatty acid desaturated enzyme of marine microalgae and applications thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101289659A CN101289659A (en) | 2008-10-22 |
CN101289659B true CN101289659B (en) | 2010-12-22 |
Family
ID=40034105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101152453A Expired - Fee Related CN101289659B (en) | 2008-06-19 | 2008-06-19 | Delta6 fatty acid desaturated enzyme of marine microalgae and applications thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101289659B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8753879B2 (en) | 2008-06-06 | 2014-06-17 | Aurora Alage, Inc. | VCP-based vectors for algal cell transformation |
US8809046B2 (en) | 2011-04-28 | 2014-08-19 | Aurora Algae, Inc. | Algal elongases |
US9029137B2 (en) | 2009-06-08 | 2015-05-12 | Aurora Algae, Inc. | ACP promoter |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8709765B2 (en) | 2009-07-20 | 2014-04-29 | Aurora Algae, Inc. | Manipulation of an alternative respiratory pathway in photo-autotrophs |
CN101889630B (en) * | 2010-06-28 | 2013-06-05 | 浙江大学 | Method for preparing polyunsaturated fatty acid-enriched weaning food |
US8722359B2 (en) | 2011-01-21 | 2014-05-13 | Aurora Algae, Inc. | Genes for enhanced lipid metabolism for accumulation of lipids |
AU2012249377A1 (en) * | 2011-04-28 | 2013-11-14 | Aurora Algae, Inc. | Algal desaturases |
CN103987401A (en) * | 2011-04-28 | 2014-08-13 | 范斯坦医药研究院 | MFG-E8 and its uses |
CN102559710B (en) * | 2011-06-27 | 2013-10-30 | 中国农业科学院油料作物研究所 | Isochrysis sphaerica delta 4-fatty acid desaturase gene and cloning method thereof |
CN102492700A (en) * | 2011-11-25 | 2012-06-13 | 上海海洋大学 | DNA sequence for coding delta15 fatty acid desaturase (FAD) of Myrmecia incisa and application thereof |
CN102851211B (en) * | 2012-08-22 | 2014-04-16 | 王培磊 | Formula of nannochloropsis oculata medium and three-stage cultivation method |
CN104450748B (en) * | 2014-11-18 | 2017-07-18 | 西南大学 | The rough fatty acid desaturase ApD6D gene families of careless △ 6 and its recombinant expression carrier and application |
-
2008
- 2008-06-19 CN CN2008101152453A patent/CN101289659B/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8753879B2 (en) | 2008-06-06 | 2014-06-17 | Aurora Alage, Inc. | VCP-based vectors for algal cell transformation |
US9029137B2 (en) | 2009-06-08 | 2015-05-12 | Aurora Algae, Inc. | ACP promoter |
US9376687B2 (en) | 2009-06-08 | 2016-06-28 | Aurora Algae, Inc. | Algal elongase 6 |
US8809046B2 (en) | 2011-04-28 | 2014-08-19 | Aurora Algae, Inc. | Algal elongases |
Also Published As
Publication number | Publication date |
---|---|
CN101289659A (en) | 2008-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101289659B (en) | Delta6 fatty acid desaturated enzyme of marine microalgae and applications thereof | |
Cahoon et al. | Plant unusual fatty acids: learning from the less common | |
Napier et al. | Understanding and manipulating plant lipid composition: metabolic engineering leads the way | |
Sayanova et al. | Identification and functional characterisation of genes encoding the omega-3 polyunsaturated fatty acid biosynthetic pathway from the coccolithophore Emiliania huxleyi | |
JP2017532949A5 (en) | ||
Venegas-Calerón et al. | An alternative to fish oils: metabolic engineering of oil-seed crops to produce omega-3 long chain polyunsaturated fatty acids | |
Warude et al. | Polyunsaturated fatty acids: biotechnology | |
Khozin-Goldberg et al. | Microalgae as a source for VLC-PUFA production | |
Faure et al. | Camelina, a Swiss knife for plant lipid biotechnology | |
Sayanova et al. | Transgenic oilseed crops as an alternative to fish oils | |
Shi et al. | Production of eicosapentaenoic acid by application of a delta-6 desaturase with the highest ALA catalytic activity in algae | |
AU2013326297B2 (en) | Recombinant organisms | |
CN102066564A (en) | Desaturase and method for the production of polyunsaturated fatty acids in transgenic organisms | |
Napier et al. | The production of very-long-chain PUFA biosynthesis in transgenic plants: towards a sustainable source of fish oils | |
Thiyagarajan et al. | Identification and functional characterization of two novel fatty acid genes from marine microalgae for eicosapentaenoic acid production | |
Petrie et al. | Isolation and characterisation of a high-efficiency desaturase and elongases from microalgae for transgenic LC-PUFA production | |
CN101210234B (en) | Ocean micro-alga delta5 aliphatic acid desaturase and application thereof | |
Cahoon et al. | Modifying vegetable oils for food and non-food purposes | |
Lee et al. | High accumulation of γ-linolenic acid and Stearidonic acid in transgenic Perilla (Perilla frutescens var. frutescens) seeds | |
Maheshwari et al. | Genetic engineering of oilseed crops | |
Prasad et al. | Identification and functional characterization of Buglossoides arvensis microsomal fatty acid desaturation pathway genes involved in polyunsaturated fatty acid synthesis in seeds | |
Dhanya et al. | Algal biotechnology: A sustainable route for omega-3 fatty acid production | |
Iskandarov et al. | Cloning and characterization of the∆ 6 polyunsaturated fatty acid elongase from the green microalga Parietochloris incisa | |
Vrinten et al. | Production of polyunsaturated fatty acids in transgenic plants | |
Kim et al. | Coexpression of multiple genes reconstitutes two pathways of very long-chain polyunsaturated fatty acid biosynthesis in Pichia pastoris |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101222 Termination date: 20130619 |